Asendin: Effective Relief for Major Depressive Disorder
| Product dosage: 50mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 30 | $1.38 | $41.30 (0%) | 🛒 Add to cart |
| 60 | $1.21 | $82.60 $72.53 (12%) | 🛒 Add to cart |
| 90 | $1.14 | $123.91 $102.75 (17%) | 🛒 Add to cart |
| 120 | $1.11 | $165.21 $132.97 (20%) | 🛒 Add to cart |
| 180 | $1.07 | $247.81 $193.42 (22%) | 🛒 Add to cart |
| 270 | $1.05 | $371.72 $284.08 (24%) | 🛒 Add to cart |
| 360 | $1.03
Best per pill | $495.63 $371.72 (25%) | 🛒 Add to cart |
Asendin (amoxapine) is a tetracyclic antidepressant medication approved for the treatment of major depressive disorder. It functions primarily by inhibiting the reuptake of norepinephrine, thereby increasing its availability in the brain to help regulate mood. Clinicians often consider it for patients who have not responded adequately to first-line SSRI treatments, due to its distinct mechanism of action. Proper diagnosis and ongoing medical supervision are essential for safe and effective use.
Features
- Active ingredient: amoxapine
- Available in 25 mg, 50 mg, 100 mg, and 150 mg oral tablets
- Tetracyclic antidepressant (TeCA) class
- Inhibits norepinephrine reuptake
- Also exhibits moderate dopamine receptor blockade
- Typically administered once or twice daily
Benefits
- Provides significant relief from symptoms of major depression, including low mood and anhedonia
- May offer faster onset of action compared to some SSRIs for certain patients
- Effective in cases where other antidepressants have provided insufficient results
- Helps restore energy levels and improve concentration
- Can alleviate anxiety symptoms often associated with depression
- Supports overall functional improvement and quality of life
Common use
Asendin is primarily indicated for the management of major depressive disorder in adults. It is often prescribed when patients have not tolerated or responded to selective serotonin reuptake inhibitors (SSRIs) or other first-line antidepressant therapies. Off-label uses are minimal and not well-supported by clinical evidence; therefore, use should be strictly guided by a healthcare provider’s assessment and diagnostic criteria.
Dosage and direction
The initial dosage for most adults is 50 mg orally, two or three times daily. Depending on patient tolerance and therapeutic response, the dosage may be gradually increased. Maintenance doses typically range from 100 mg to 300 mg per day, though doses above 300 mg daily are not recommended. Dosage adjustments should be made under close medical supervision, especially in elderly patients or those with hepatic impairment. Tablets should be swallowed whole, with or without food.
Precautions
Patients should be monitored for worsening depression, suicidality, or unusual changes in behavior, especially during the initial months of therapy or following dosage changes. Caution is advised in individuals with a history of seizures, cardiovascular disease, urinary retention, or angle-closure glaucoma. Regular assessment of hepatic and renal function may be necessary during long-term treatment. Asendin may impair mental or physical abilities required for driving or operating machinery.
Contraindications
Asendin is contraindicated in patients with known hypersensitivity to amoxapine or any component of the formulation. It should not be used concomitantly with monoamine oxidase inhibitors (MAOIs) or within 14 days of discontinuing MAOI therapy due to risk of serotonin syndrome. Additional contraindications include recovery phase following myocardial infarction and patients with severe liver impairment.
Possible side effect
Common side effects may include drowsiness, dizziness, dry mouth, constipation, blurred vision, and weight gain. Less frequently, patients may experience orthostatic hypotension, tachycardia, urinary retention, or increased sweating. Although rare, serious adverse effects such as seizures, neuroleptic malignant syndrome, extrapyramidal symptoms, and agranulocytosis have been reported. Any persistent or severe side effects should be promptly reported to a healthcare provider.
Drug interaction
Asendin may interact with MAOIs, leading to potentially fatal serotonin syndrome. Concomitant use with other CNS depressants (e.g., alcohol, benzodiazepines, opioids) may enhance sedative effects. It may also potentiate the effects of antihypertensive drugs and increase the risk of arrhythmias with other QT-prolonging agents. Caution is advised when using with anticholinergic drugs, tramadol, or serotonergic agents.
Missed dose
If a dose is missed, it should be taken as soon as remembered unless it is nearly time for the next scheduled dose. In that case, the missed dose should be skipped, and the regular dosing schedule resumed. Doubling the dose to make up for a missed one is not recommended. Patients should consult their prescriber if multiple doses are missed or if uncertainty exists regarding dosing.
Overdose
Overdose with Asendin can be severe and potentially fatal. Symptoms may include severe drowsiness, tachycardia, hypotension, convulsions, coma, and cardiac arrhythmias. Management involves immediate medical attention, supportive care, and symptomatic treatment. Gastric lavage and activated charcoal may be considered if ingestion was recent. There is no specific antidote; treatment focuses on stabilizing vital signs and managing complications.
Storage
Store at room temperature (20–25°C or 68–77°F), in a tightly closed container, away from light, moisture, and heat. Keep out of reach of children and pets. Do not use beyond the expiration date printed on the packaging. Dispose of unused medication through a medicine take-back program or according to local guidelines to prevent accidental ingestion or environmental contamination.
Disclaimer
This information is intended for educational purposes and does not replace professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before starting, changing, or discontinuing any medication. Individual patient needs and responses may vary.
Reviews
Clinical studies and patient reports indicate that Asendin can be effective for individuals with treatment-resistant depression, though experiences with side effects vary. Some users note improvement in mood and energy within several weeks, while others emphasize the importance of dose titration and monitoring. Overall, it remains a valuable option under appropriate medical guidance.